EGFR mutations in relation to EGFR copy number (A), mRNA (B), protein (C), and genome-wide aneuploidy (D) levels and overall mutational burden (E) in HNSCC patients curated in the cBioPortal for Cancer Genomics. EGFR mutations rarely co-segregate with EGFR amplifications (A) and show ranges of EGFR mRNA (B) and protein (C) expression comparable to their non-amplified counterparts. EGFR mutated tumors show a range of chromosomal aneuploidy scores (D) similar to non-mutated tumors, but demonstrate a significantly lower overall mutational burden (E). EGFR genomic, and aneuploidy, and mutational count data were visualized, analyzed, and downloaded from the cBioPortal for Cancer Genomics (https://www.cbioportal.org; accessed on 19 March 2022 [22,23]).